Preference-based instrumental variable methods for the estimation of treatment effects: Assessing validity and interpreting results

International Journal of Biostatistics

Volumn 3, Issue 1, 2007, Pages

  Brookhart, M Alan ^a   Schneeweiss, Sebastian ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Instrumental variables methods; Outcomes research; Pharmacoepidemiology

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ADULT; AGED; ALCOHOLISM; ANALGESIA; ARTICLE; CLINICAL DECISION MAKING; CLINICAL OBSERVATION; CONCEPTUAL FRAMEWORK; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENETIC HETEROGENEITY; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOMES RESEARCH; PEPTIC ULCER; PRACTICE GUIDELINE; PREFERENCE BASED INSTRUMENTAL VARIABLE METHOD; PRESCRIPTION; PROGNOSIS; RISK ASSESSMENT; SMOKING; STATISTICAL ANALYSIS; STOMACH PROTECTION; VALIDATION STUDY; CAUSAL INFERENCE; CHEMICALLY INDUCED DISORDER; CLINICAL PRACTICE; COMPARATIVE STUDY; GASTROINTESTINAL DISEASE; HEALTH SERVICES RESEARCH; INSTRUMENTAL VARIABLES; PHARMACOEPIDEMIOLOGY; PHYSICIAN; RANDOMIZATION; TREATMENT OUTCOME; UNMEASURED CONFOUNDING;

CAUSAL INFERENCE; HEALTH SERVICES RESEARCH; INSTRUMENTAL VARIABLES; OUTCOMES RESEARCH; PHARMACOEPIDEMIOLOGY; UNMEASURED CONFOUNDING;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DATA INTERPRETATION, STATISTICAL; GASTROINTESTINAL DISEASES; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; RANDOM ALLOCATION; TREATMENT OUTCOME;

EID: 37849042876     PISSN: 15574679     EISSN: None     Source Type: Journal    
DOI: 10.2202/1557-4679.1072     Document Type: Article

References (29)

1. Walker A. Confounding by indication. Epidemiology 1996; 7(4): 335-6.
2. Angrist J, Imbens G, Rubin DB. Identification of causal effects using in-strumental variable. J Amer Stat Assoc. 1996; 91(434): 444-455.
3. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000; 29: 722-729.
4. Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Instrumental variables: application and limitations. Epidemiology. 2006; 17(3): 260-7.
5. Herńan MA, Robins JM. Instruments for causal inference: an epidemiologist's dream? Epidemiology. 2006; 17(4): 360-72.
6. Wen SW, Kramer MS. Uses of ecologic studies in the assessment of intended treatment effects. J Clin Epidemiol. 1999; 52(1): 7-12.
7. Brooks JM, Chrischilles EA, Scott SD, Chen-Hardee SS. Was breast conserving surgery underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa. Health Serv Res. 2003; 38(6 Pt 1): 1385-402.
8. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007; 297(3): 278-85.
9. Johnston SC. Combining ecological and individual variables to reduce confounding by indication: case study-subarachnoid hemorrhage treatment. J Clin Epidemiol. 2000; 53(12): 1236-41
10. Brookhart MA. Assessing the safety of recombinant erythropoietin using instrumental variable methods [abstract]. Meeting of the International Biometrics Society, Eastern North American Region, Atlanta, Georgia, 2007.
11. Korn MA, Baumrind E. Clinician preferences and the estimation of causal treatment differences. Statistical Science. 1998; 13(3): 209-35.
12. Brookhart MA, Wang PS, Solomon DH, Schneeweiss S. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology. 2006; 17(3): 268-75.
13. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005; 353(22): 2335-41.
14. Laporte JR, Ibanez L, Vidal X, Vendrell L, Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf. 2004; 27(6): 411-20.
15. Solomon DH, Schneeweiss S, Glynn RJ, Levin R, Avorn J. Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? Am J Med. 2003; 115(9): 715-20.
16. Schneeweiss S, Glynn RJ, Avorn J, Solomon DH. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. J Clin Epidemiol. 2005; 58(1): 98-102.
17. Brookhart MA, Polinski JM, Avorn J, Mogun H, Solomon DH. The medical license number accurately identifies the prescribing physician in a large pharmacy claims dataset. Med Care. 2007; 45(9): 907-910.
18. Rubin DB. Estimating causal effects of treatment in randomized and non-randomized studies. Journal of Eductional Psychology. 1974; 66: 688-701.
19. Rubin DB. Statistics and causal inference. Comment: which ifs have causal answers? J Amer Stat Assoc. 1986; 81: 961-962.
20. Imbens G, Angrist J. Identification and estimation of local average treatment effects. Econometrica. 1994; 62 (2): 467-476.
21. Harris KM. Remler DK. Who is the marginal patient? Understanding instrumental variables estimates of treatment effects. Health Serv Res. 1998; 33(5 Pt 1): 1337-60.
22. Wooldridge J. On two-stage least squares estimation of the average treatment effect in a random coefficient model. Economic Letters. 1997; 56: 129133
23. Heckman JJ, Urzua S, Vytlacil EJ. Understanding instrumental variable models with essential heterogeneity. NBER working paper, 12574, 2006.
24. Bound J, Jaeger DA, Baker RM. Problems with instrumental variables estimation when the correlation between the instruments and the endogenous explanatory variable is weak. J Am Stat Assoc. 1995; 90: 443-450.
25. Small D, Rosenbaum PR. War and Wages: The strength of instrumental variables and their sensitivity to unobserved biases. J Am Stat Assoc. In press.
26. Ray WA. Observational studies of drugs and mortality. N Engl J Med. 2005; 353(22): 2319-2321.
27. De Smet BD, Fendrick MA, Stevenson JG, Bernstein SJ. Over and Under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists: the tortoise and the hare revisited. J Gen Intern Med. 2006; 21: 694-697.
28. Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003(b); 115(5): 398-400.
29. Majumdar SR, Gurwitz JH, Soumerai SB. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. J Gen Intern Med. 1999; 14: 711-717.